Immunotherapeutic Strategies for Alzheimer's Disease Treatment
Naturally occurring antibodies against amyloid-β peptides have been found in human cerebrospinal fluid and in the plasma of healthy individuals, but were significantly lower in Alzheimer's disease (AD) patients, suggesting that AD may be an immunodeficient disorder. The performance of anti-amyl...
Saved in:
Main Author: | Beka Solomon |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2009-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/tsw.2009.99 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vaccines and Immunotherapeutics for the Treatment of Malignant Disease
by: Joel F. Aldrich, et al.
Published: (2010-01-01) -
Immunotherapeutic Targeting in Autoimmune Diseases
by: Nona Janikashvili, et al.
Published: (2016-01-01) -
New Immunotherapeutic Approaches for Glioblastoma
by: Gustavo Ignacio Vázquez Cervantes, et al.
Published: (2021-01-01) -
Polymers for the treatment of Alzheimer’s disease
by: Yunfeng Zhu, et al.
Published: (2025-01-01) -
Novel Immunotherapeutic Approaches for Neuroblastoma and Malignant Melanoma
by: Fabio Morandi, et al.
Published: (2018-01-01)